A Stock Overview
Provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. More details
Snowflake Score | |
---|---|
Valuation | 3/6 |
Future Growth | 2/6 |
Past Performance | 5/6 |
Financial Health | 4/6 |
Dividends | 0/6 |
Rewards
Risk Analysis
No risks detected for A from our risk checks.
My Notes
Capture your thoughts, links and company narrative
Community Narratives
Create a narrativeNarratives bring a range of perspectives from our community.
Agilent Technologies, Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$134.51 |
52 Week High | US$155.35 |
52 Week Low | US$124.16 |
Beta | 1.06 |
1 Month Change | 0.50% |
3 Month Change | -3.78% |
1 Year Change | -3.63% |
3 Year Change | -14.76% |
5 Year Change | 57.47% |
Change since IPO | 214.64% |
Recent News & Updates
Is There Now An Opportunity In Agilent Technologies, Inc. (NYSE:A)?
Dec 13Analyst Estimates: Here's What Brokers Think Of Agilent Technologies, Inc. (NYSE:A) After Its Full-Year Report
Nov 28Agilent Q4: Expecting Market Recovery In 2025
Nov 26Agilent Technologies' (NYSE:A) Shareholders Will Receive A Bigger Dividend Than Last Year
Nov 26Recent updates
Is There Now An Opportunity In Agilent Technologies, Inc. (NYSE:A)?
Dec 13Analyst Estimates: Here's What Brokers Think Of Agilent Technologies, Inc. (NYSE:A) After Its Full-Year Report
Nov 28Agilent Q4: Expecting Market Recovery In 2025
Nov 26Agilent Technologies' (NYSE:A) Shareholders Will Receive A Bigger Dividend Than Last Year
Nov 26Here's Why Agilent Technologies (NYSE:A) Can Manage Its Debt Responsibly
Oct 21With EPS Growth And More, Agilent Technologies (NYSE:A) Makes An Interesting Case
Sep 23Agilent Technologies' (NYSE:A) Profits May Not Reveal Underlying Issues
Sep 09Agilent: A 'Buy' Due To Growing Biopharma, PFAS, And Semi
Aug 23A Look At The Intrinsic Value Of Agilent Technologies, Inc. (NYSE:A)
Aug 14Agilent: Making A Move To Ignite Some Growth
Jul 25Agilent Technologies (NYSE:A) Has A Pretty Healthy Balance Sheet
Jul 15Is Agilent A Buy Before Earnings? Examining The Pros And Cons
May 23Should You Investigate Agilent Technologies, Inc. (NYSE:A) At US$154?
May 22Subdued Growth No Barrier To Agilent Technologies, Inc.'s (NYSE:A) Price
May 07These 4 Measures Indicate That Agilent Technologies (NYSE:A) Is Using Debt Reasonably Well
Apr 05Agilent Technologies: Cash Flow Returns On Investments And Conventional All Point To A Hold
Mar 12Agilent Technologies Hit A Homerun
Dec 24Agilent: A Wide Moat Company Expected To Return To Growth In 2024 (Rating Upgrade)
Dec 08Agilent Technologies: Looking Undervalued Heading Into Earnings
Nov 17Agilent: Dips Into GARP Territory, Shares At A Crucial Spot On The Chart
Sep 26Agilent Technologies - A Wealth Compounder 30% Below Its Highs
Jul 13Shareholder Returns
A | US Life Sciences | US Market | |
---|---|---|---|
7D | -3.2% | -2.1% | -2.4% |
1Y | -3.6% | -5.5% | 23.3% |
Return vs Industry: A exceeded the US Life Sciences industry which returned -5.5% over the past year.
Return vs Market: A underperformed the US Market which returned 23.3% over the past year.
Price Volatility
A volatility | |
---|---|
A Average Weekly Movement | 3.8% |
Life Sciences Industry Average Movement | 9.2% |
Market Average Movement | 6.3% |
10% most volatile stocks in US Market | 16.8% |
10% least volatile stocks in US Market | 3.1% |
Stable Share Price: A has not had significant price volatility in the past 3 months compared to the US market.
Volatility Over Time: A's weekly volatility (4%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1999 | 18,000 | Padraig McDonnell | www.agilent.com |
Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.
Agilent Technologies, Inc. Fundamentals Summary
A fundamental statistics | |
---|---|
Market cap | US$38.42b |
Earnings (TTM) | US$1.29b |
Revenue (TTM) | US$6.51b |
29.8x
P/E Ratio5.9x
P/S RatioIs A overvalued?
See Fair Value and valuation analysisEarnings & Revenue
A income statement (TTM) | |
---|---|
Revenue | US$6.51b |
Cost of Revenue | US$2.98b |
Gross Profit | US$3.54b |
Other Expenses | US$2.25b |
Earnings | US$1.29b |
Last Reported Earnings
Oct 31, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | 4.51 |
Gross Margin | 54.30% |
Net Profit Margin | 19.80% |
Debt/Equity Ratio | 57.5% |
How did A perform over the long term?
See historical performance and comparisonDividends
0.7%
Current Dividend Yield21%
Payout RatioDoes A pay a reliable dividends?
See A dividend history and benchmarksAgilent Technologies dividend dates | |
---|---|
Ex Dividend Date | Dec 31 2024 |
Dividend Pay Date | Jan 22 2025 |
Days until Ex dividend | 9 days |
Days until Dividend pay date | 31 days |
Does A pay a reliable dividends?
See A dividend history and benchmarksCompany Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2024/12/22 01:37 |
End of Day Share Price | 2024/12/20 00:00 |
Earnings | 2024/10/31 |
Annual Earnings | 2024/10/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Agilent Technologies, Inc. is covered by 43 analysts. 18 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
James Francis Mainwaring | Atlantic Equities LLP |
Catherine Ramsey Schulte | Baird |
Ishan Majumdar | Baptista Research |